These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28853185)

  • 21. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
    Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
    J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient growth inhibition of EGFR over-expressing tumor cells by an anti-EGFR nanobody.
    Omidfar K; Amjad Zanjani FS; Hagh AG; Azizi MD; Rasouli SJ; Kashanian S
    Mol Biol Rep; 2013 Dec; 40(12):6737-45. PubMed ID: 24052234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimized refolding and characterization of active C-terminal ADAMTS-18 fragment from inclusion bodies of Escherichia coli.
    Dang S; Hong T; Bu D; Tang J; Fan J; Zhang W
    Protein Expr Purif; 2012 Mar; 82(1):32-6. PubMed ID: 22119775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multivalent nanobodies targeting death receptor 5 elicit superior tumor cell killing through efficient caspase induction.
    Huet HA; Growney JD; Johnson JA; Li J; Bilic S; Ostrom L; Zafari M; Kowal C; Yang G; Royo A; Jensen M; Dombrecht B; Meerschaert KR; Kolkman JA; Cromie KD; Mosher R; Gao H; Schuller A; Isaacs R; Sellers WR; Ettenberg SA
    MAbs; 2014; 6(6):1560-70. PubMed ID: 25484045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A bispecific nanobody targeting the dimerization interface of epidermal growth factor receptor: Evidence for tumor suppressive actions in vitro and in vivo.
    Xu Z; Qiu C; Wen B; Wang S; Zhu L; Zhao L; Li H
    Biochem Biophys Res Commun; 2021 Apr; 548():78-83. PubMed ID: 33636638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fenobody: A Ferritin-Displayed Nanobody with High Apparent Affinity and Half-Life Extension.
    Fan K; Jiang B; Guan Z; He J; Yang D; Xie N; Nie G; Xie C; Yan X
    Anal Chem; 2018 May; 90(9):5671-5677. PubMed ID: 29634235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression, purification, refolding and in vitro recovery of active full length recombinant human gelatinase MMP-9 in Escherichia coli.
    Mohseni S; Moghadam TT; Dabirmanesh B; Khajeh K
    Protein Expr Purif; 2016 Oct; 126():42-48. PubMed ID: 27164034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [AntiEGFRnano inhibites proliferation and migration of estrogen-dependent Ishikawa cells of human endometrial cancer cell line].
    Diao ZY; Lu WG; Cao P; Hu YL; Zhou X; Xue PP; Shen L; Sun HX
    Yao Xue Xue Bao; 2012 Oct; 47(10):1341-6. PubMed ID: 23289147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation and characterization of a human nanobody against VEGFR-2.
    Ma L; Gu K; Zhang CH; Chen XT; Jiang Y; Melcher K; Zhang J; Wang M; Xu HE
    Acta Pharmacol Sin; 2016 Jun; 37(6):857-64. PubMed ID: 27108602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and characterization of nanobodies against epithelial cell adhesion molecule as novel theranostic agents for cancer therapy.
    Roshan R; Naderi S; Behdani M; Cohan RA; Ghaderi H; Shokrgozar MA; Golkar M; Kazemi-Lomedasht F
    Mol Immunol; 2021 Jan; 129():70-77. PubMed ID: 33183767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Affinity enhancement of nanobody binding to EGFR: in silico site-directed mutagenesis and molecular dynamics simulation approaches.
    Farasat A; Rahbarizadeh F; Hosseinzadeh G; Sajjadi S; Kamali M; Keihan AH
    J Biomol Struct Dyn; 2017 Jun; 35(8):1710-1728. PubMed ID: 27691399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paper Title "Hu7CG2: A Novel Humanized Anti-Epidermal Growth Factor Receptor (EGFR) Biparatopic Nanobody".
    Sharifi J; Khirehgesh MR; Akbari B; Soleymani B; Mansouri K
    Mol Biotechnol; 2021 Jun; 63(6):525-533. PubMed ID: 33772436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of EGFR by a novel multivalent nanobody-liposome platform.
    Oliveira S; Schiffelers RM; van der Veeken J; van der Meel R; Vongpromek R; van Bergen En Henegouwen PM; Storm G; Roovers RC
    J Control Release; 2010 Jul; 145(2):165-75. PubMed ID: 20362020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A high affinity nanobody against endothelin receptor type B: a new approach to the treatment of melanoma.
    Ji L; Dong C; Fan R; Qi S
    Mol Biol Rep; 2020 Mar; 47(3):2137-2147. PubMed ID: 32080807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of buffer additives on solubilization and refolding of reteplase inclusion bodies.
    Esmaili I; Mohammad Sadeghi HM; Akbari V
    Res Pharm Sci; 2018 Oct; 13(5):413-421. PubMed ID: 30271443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement of solubility and refolding of an anti-human epidermal growth factor receptor 2 single-chain antibody fragment inclusion bodies.
    Salehinia J; Sadeghi HMM; Abedi D; Akbari V
    Res Pharm Sci; 2018 Dec; 13(6):566-574. PubMed ID: 30607154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preparation and identification of anti-follicle-stimulating hormone receptor nanobodies].
    Xia X; M M; Zhai T; Li J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):829-33. PubMed ID: 23948408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Refolding and purification of yeast carboxypeptidase Y expressed as inclusion bodies in Escherichia coli.
    Hahm MS; Chung BH
    Protein Expr Purif; 2001 Jun; 22(1):101-7. PubMed ID: 11388806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refolding and purification of recombinant human VEGF-121 expressed as inclusion bodies in Escherichia coli.
    Hu ZM; Ma L; Zhou MQ; Gao JM; Wang XN
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1083-6. PubMed ID: 16939889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification of recombinant ovalbumin from inclusion bodies of Escherichia coli.
    Upadhyay V; Singh A; Panda AK
    Protein Expr Purif; 2016 Jan; 117():52-8. PubMed ID: 26390939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.